Market cap
$3,636 Mln
Revenue (TTM)
$562 Mln
P/E Ratio
32.3
P/B Ratio
2.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.09 | 15.49 | 17.28 | 19.58 | 28.97 |
| EBIT | -35.13 | 1,455.44 | 379.79 | 79.75 | 29.42 |
| Net Profit | -11.21 | 2,701.02 | 334.72 | 81.10 | 30.71 |
| EPS | -12.19 | 2,627.52 | 323.19 | 76.45 | 27.70 |
| Book Value | -- | -- | 9.33 | 2.44 | 17.26 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -0.75 | -10.31 | 19.39 | 13.19 | 5.78 |
| Net Margin
| -- | -23.26 | 20.37 | -- | -- |
| Return on equity
| 0.16 | -2.57 | 8.49 | 5.34 | 2.17 |
| Return on Capital
| 0.11 | -2.55 | -- | 5.15 | 2.11 |
| Return on Assets
| 0.12 | -2.39 | 7.71 | 4.90 | 2.00 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.03 | 0.04 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
5.15
|
2.11
|
-6.93
|
-3.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
8.49
Higher than Peers by 48.67
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
8.49
|
5.34
|
2.17
|
-7.02
|
-3.37
|
|
Peer Median
|
-40.19
|
--
|
--
|
--
|
--
|
ROA
7.71
Higher than Peers by 39.18
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
7.71
|
4.90
|
2.00
|
-6.55
|
-3.12
|
|
Peer Median
|
-31.47
|
--
|
--
|
--
|
--
|
EBIT Margin
19.39
Higher than Peers by 95.94
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
19.39
|
13.19
|
5.78
|
-21.22
|
-12.22
|
|
Peer Median
|
-76.56
|
--
|
--
|
--
|
--
|
Net Margin
20.37
Higher than Peers by 107.81
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
20.37
|
12.83
|
5.41
|
-20.61
|
-12.14
|
|
Peer Median
|
-87.44
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
17.28
Lower than Peers by 42.27
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
17.28
|
0.16
|
0.23
|
0.22
|
0.35
|
|
Peer Median
|
59.55
|
--
|
--
|
--
|
--
|
EBIT Growth
379.79
Higher than Peers by 381.22
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
379.79
|
164.90
|
133.61
|
-111.42
|
55.50
|
|
Peer Median
|
-1.44
|
--
|
--
|
--
|
--
|
Net Profit Growth
334.72
Higher than Peers by 342.34
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
334.72
|
174.89
|
132.44
|
-103.51
|
51.62
|
|
Peer Median
|
-7.62
|
--
|
--
|
--
|
--
|
EPS Growth
323.19
Higher than Peers by 309.87
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
323.19
|
1.70
|
1.30
|
-1.00
|
0.52
|
|
Peer Median
|
13.32
|
--
|
--
|
--
|
--
|
Book Value Growth
10.50
Higher than Peers by 19.48
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
10.50
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-8.99
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
0.03
|
0.04
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
0.00
|
0.00
|
0.01
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
9.16
Higher than Peers by 3.27
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
9.16
|
8.15
|
4.73
|
4.66
|
3.97
|
|
Peer Median
|
5.89
|
--
|
--
|
--
|
--
|
Quick Ratio
8.80
Higher than Peers by 3.05
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
8.80
|
7.81
|
4.46
|
4.40
|
3.74
|
|
Peer Median
|
5.75
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
68,201.00
|
12,873.00
|
-5,106.47
|
-182.97
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
9.64
Lower than Peers by 9.52
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
9.64
|
8.64
|
10.44
|
11.18
|
14.85
|
|
Peer Median
|
19.16
|
--
|
--
|
--
|
--
|
Asset Turnover
0.38
Higher than Peers by 0.31
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
0.38
|
0.38
|
0.37
|
0.32
|
0.25
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
32.20
|
35.60
|
42.69
|
52.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
49.17
|
46.86
|
49.21
|
45.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
15.38
|
26.69
|
40.20
|
43.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
65.99
|
55.77
|
51.70
|
54.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
32.31
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
32.31
|
51.64
|
131.09
|
-27.03
|
-46.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
2.54
Lower than Peers by 1.94
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
2.54
|
2.62
|
2.69
|
1.93
|
1.59
|
|
Peer Median
|
4.48
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
22.51
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
22.51
|
34.07
|
59.46
|
-36.58
|
-149.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
3,636
Higher than Peers by 3,499
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Veracyte (VCYT)
|
3,636
|
--
|
--
|
--
|
--
|
|
Peer Median
|
137
|
--
|
--
|
--
|
--
|